Recent studies have identified the enzyme pyrroline-5-carboxylate reductase 1 (PYCR1) as a potential contributor to cancer progression5,6, but its specific role and underlying mechanisms in lung cancer have not been fully elucidated. The gene discussed is PYCR1; the disease is lung carcinoma.